Christopher J. Kochansky

556 total citations
21 papers, 428 citations indexed

About

Christopher J. Kochansky is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Christopher J. Kochansky has authored 21 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Physiology. Recurrent topics in Christopher J. Kochansky's work include Peroxisome Proliferator-Activated Receptors (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Adipose Tissue and Metabolism (4 papers). Christopher J. Kochansky is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Adipose Tissue and Metabolism (4 papers). Christopher J. Kochansky collaborates with scholars based in United States, Spain and Switzerland. Christopher J. Kochansky's co-authors include Timothy G. Strein, Magang Shou, Daniel R. McMasters, Stella Vincent, Ping Lü, Kenneth A. Koeplinger, Kenneth R. Korzekwa, Ronald B. Franklin, Maria Beconi and Jae H. Chang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Cancer Research.

In The Last Decade

Christopher J. Kochansky

21 papers receiving 415 citations

Peers

Christopher J. Kochansky

ONCOL

PHARM

Jeffrey Sarver United States

Suresh P. Sulochana India

Duanyun Si China

Deen Han China

Murali Subramanian India

Graham Somers United Kingdom

Kiminori Mohri Japan

Angela Wolford United States

Mohd Usman Mohd Siddique India

Olaf Kuhlmann Switzerland

Jeffrey Sarver United States

Christopher J. Kochansky

204 ×1.2

102 ×1.1

ONCOL

53 ×0.8

PHARM

66 ×1.1

48 ×0.9

PHARM

Citations per year, relative to Christopher J. Kochansky Christopher J. Kochansky (= 1×) peers Jeffrey Sarver

Countries citing papers authored by Christopher J. Kochansky

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Kochansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Kochansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Kochansky more than expected).

Fields of papers citing papers by Christopher J. Kochansky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Kochansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Kochansky. The network helps show where Christopher J. Kochansky may publish in the future.

Co-authorship network of co-authors of Christopher J. Kochansky

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Kochansky. A scholar is included among the top collaborators of Christopher J. Kochansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Kochansky. Christopher J. Kochansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumar, Aditya, Scott P. Simonovich, Christopher J. Kochansky, et al.. (2025). Abstract 5723: XL309 is a potent, selective, and orally bioavailable USP1 inhibitor active as monotherapy and in combination with PARP inhibitors or irinotecan. Cancer Research. 85(8_Supplement_1). 5723–5723. 1 indexed citations

Kochansky, Christopher J., Mark T. Cancilla, Mark Wrona, et al.. (2020). Metabolite identification using an ion mobility enhanced data‐independent acquisition strategy and automated data processing. Rapid Communications in Mass Spectrometry. 34(12). e8792–e8792. 13 indexed citations

Kochansky, Christopher J., et al.. (2019). Decreased liver triglyceride content in adult rats exposed to protein restriction during gestation and lactation: roles of hepatic lipogenesis and lipid utilization in muscle and adipose tissue. Canadian Journal of Physiology and Pharmacology. 97(10). 952–962. 1 indexed citations

Kochansky, Christopher J., et al.. (2018). Administration of Fenofibrate Markedly Elevates Fabp3 in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity. Lipids. 53(10). 947–960. 5 indexed citations

Brink, Andreas, et al.. (2017). Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry. PLoS ONE. 12(11). e0186461–e0186461. 14 indexed citations

Parmar, Rubina, Eileen S. Walsh, Karen Leander, et al.. (2013). Endosomolytic Bioreducible Poly(amido amine disulfide) Polymer Conjugates for the in Vivo Systemic Delivery of siRNA Therapeutics. Bioconjugate Chemistry. 24(4). 640–647. 33 indexed citations

Fisher, Thorsten E., Bo-Young Kim, Terry A. Lyle, et al.. (2007). 8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(23). 6511–6515. 31 indexed citations

Beconi, Maria, James R. Reed, Yohannes Teffera, et al.. (2007). Disposition of the Dipeptidyl Peptidase 4 Inhibitor Sitagliptin in Rats and Dogs. Drug Metabolism and Disposition. 35(4). 525–532. 52 indexed citations

Lyle, Terry A., Daniel R. McMasters, Philip E.J. Sanderson, et al.. (2006). Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability. Bioorganic & Medicinal Chemistry. 14(20). 6900–6916. 31 indexed citations

10.

Kochansky, Christopher J., Michael A. Wallace, Dennis Dean, et al.. (2006). Absorption, Metabolism, and Excretion of [14C]MK-0767 (2-Methoxy-5-(2,4-dioxo-5-thiazolidinyl)-N-[[4-(trifluoromethyl)phenyl] methyl]benzamide) in Humans. Drug Metabolism and Disposition. 34(9). 1457–1461. 5 indexed citations

11.

Chang, Jae H., Christopher J. Kochansky, & Magang Shou. (2006). The Role of P-glycoprotein in the Bioactivation of Raloxifene. Drug Metabolism and Disposition. 34(12). 2073–2078. 18 indexed citations

12.

Kochansky, Christopher J., et al.. (2005). SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE. Drug Metabolism and Disposition. 33(12). 1894–1904. 9 indexed citations

13.

Kochansky, Christopher J., et al.. (2005). Increasing the Efficiency of In-Capillary Electrophoretically Mediated Microanalysis Reactions via Rapid Polarity Switching. Analytical Chemistry. 77(8). 2332–2337. 25 indexed citations

14.

Doss, George A., et al.. (2004). IDENTIFICATION AND METABOLISM OF A NOVEL DIHYDROHYDROXY-S-GLUTATHIONYL CONJUGATE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST, MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], IN RATS. Drug Metabolism and Disposition. 32(10). 1154–1161. 7 indexed citations

15.

Kim, Misook, Sui Wang, Zhongzhou Shen, et al.. (2004). DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS. Drug Metabolism and Disposition. 32(9). 909–914. 28 indexed citations

16.

Shen, Zhongzhou, Christopher J. Kochansky, Ray Bakhtiar, Ronald B. Franklin, & Stella Vincent. (2004). Simultaneous determination of MK‐0767 and seven metabolites in rat urine using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 18(18). 2113–2120. 3 indexed citations

17.

Shen, Z., et al.. (2004). Differences in the metabolism and pharmacokinetics of two structurally similar PPAR agonists in dogs: involvement of taurine conjugation. Xenobiotica. 34(7). 665–674. 5 indexed citations

18.

Beconi, Maria, David Q. Liu, Christopher J. Kochansky, et al.. (2003). METABOLISM AND PHARMACOKINETICS OF A DIPEPTIDYL PEPTIDASE IV INHIBITOR IN RATS, DOGS, AND MONKEYS WITH SELECTIVE CARBAMOYL GLUCURONIDATION OF THE PRIMARY AMINE IN DOGS. Drug Metabolism and Disposition. 31(10). 1269–1277. 17 indexed citations

19.

Kochansky, Christopher J., et al.. (2001). Electrophoretically mediated microanalysis with small molecules: The Jaffé method for creatinine carried out in a capillary tube. Electrophoresis. 22(12). 2518–2525. 15 indexed citations

20.

Kochansky, Christopher J. & Timothy G. Strein. (2000). Determination of uremic toxins in biofluids: creatinine, creatine, uric acid and xanthines. Journal of Chromatography B Biomedical Sciences and Applications. 747(1-2). 217–227. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact